Anthera Pharmaceuticals Inc. rallied sharply after it was rated “outperform’’ in new coverage by Leerink Swann & Co., which cited prospects for the drugs Anthera is testing for systemic lupus erythematosis and acute coronary syndrome.
© Copyright 2011 Globe Newspaper Company.
